XML 91 R77.htm IDEA: XBRL DOCUMENT
v3.24.2

Equity - Summary of the Warrants (Details) - $ / shares | Dec. 31, 2023 | Jul. 31, 2023 | May 18, 2023 | Apr. 10, 2023
--- | --- | --- | --- | ---
Stockholders Equity Details [Line Items] |  |  |  |  |
Number of shares |  | 7,070,627 |  |  |
Exercise price |  |  |  |  | $ 7.5
Dragasac Warrant |  |  |  |  |
Stockholders Equity Details [Line Items] |  |  |  |  |
Number of shares | [1] | 652,981 |  |  |
Exercise price | [1] | $ 67.7 |  |  |
Expiration date | [1] | Mar. 16, 2025 |  |  |
Public Warrants |  |  |  |  |
Stockholders Equity Details [Line Items] |  |  |  |  |
Number of shares | [2] | 1,437,447 |  |  |
Exercise price | [2] | $ 115 |  |  |
Expiration date | [2] | Jul. 16, 2026 |  |  |
Sponsor Warrants |  |  |  |  |
Stockholders Equity Details [Line Items] |  |  |  |  |
Number of shares | [2] | 849,999 |  |  |
Exercise price | [2] | $ 115 |  |  |
Expiration date | [2] | Jul. 16, 2026 |  |  |
May 2022 PIPE Warrants |  |  |  |  |
Stockholders Equity Details [Line Items] |  |  |  |  |
Number of shares |  | 405,405 | 405,405 |  |
Exercise price |  | $ 3.5 |  |  |
Expiration date |  | Oct. 10, 2028 |  |  |
March 2023 PIPE Warrants |  |  |  |  |
Stockholders Equity Details [Line Items] |  |  |  |  |
Number of shares |  | 208,485 |  |  |
Exercise price |  | $ 30 |  |  |
Expiration date |  | Mar. 27, 2028 |  |  |
March 2023 PIPE Warrants (modified) |  |  |  |  |
Stockholders Equity Details [Line Items] |  |  |  |  |
Number of shares |  | 729,698 |  |  |
Exercise price |  | $ 10 |  |  |
Expiration date |  | Mar. 27, 2028 |  |  |
March 2023 Loan Warrants |  |  |  |  |
Stockholders Equity Details [Line Items] |  |  |  |  |
Number of shares |  | 75,000 |  |  |
Exercise price |  | $ 7.1 |  |  |
Expiration date |  | Mar. 17, 2028 |  |  |
April 2023 Registered Direct Warrants |  |  |  |  |
Stockholders Equity Details [Line Items] |  |  |  |  |
Number of shares |  | 435,625 |  |  |
Exercise price |  | $ 7.5 |  |  |
Expiration date |  | Oct. 10, 2028 |  |  |
April 2023 Registered Direct Warrants (Modified) |  |  |  |  |
Stockholders Equity Details [Line Items] |  |  |  |  |
Number of shares |  | 487,451 | 487,451 |  |
Exercise price |  | $ 3.5 |  |  |
Expiration date |  | Oct. 10, 2028 |  |  |
May 2023 PIPE Warrants |  |  |  |  |
Stockholders Equity Details [Line Items] |  |  |  |  |
Number of shares |  | 581,394 |  |  |
Exercise price |  | $ 10 |  | $ 10 |
Expiration date |  | May 17, 2028 |  | May 18, 2028 |
June 2023 Warrants |  |  |  |  |
Stockholders Equity Details [Line Items] |  |  |  |  |
Number of shares |  | 50,000 |  |  |
Exercise price |  | $ 8.1 |  |  |
Expiration date |  | Jun. 20, 2028 |  |  |
June 2023 Loan Warrants |  |  |  |  |
Stockholders Equity Details [Line Items] |  |  |  |  |
Number of shares |  | 300,000 |  |  |
Exercise price |  | $ 8.1 |  |  |
Expiration date |  | Jun. 20, 2028 |  |  |
July 2023 Registered Direct Warrants |  |  |  |  |
Stockholders Equity Details [Line Items] |  |  |  |  |
Number of shares |  | 857,142 |  |  |
Exercise price |  | $ 3.5 |  |  |
Expiration date |  | Jan. 31, 2029 |  |  |
[1] | The exercise price is the lesser of $67.70 per share or 80% of either (i) the value attributed to one share of Legacy Celularity Series B Preferred Stock upon consummation of a change in control or the closing of a strategic transaction or (ii) the price at which one share of common stock is sold to the public market in an initial public offering.
[2] | The number of Public Warrants and Sponsor Warrants outstanding was not adjusted for the reverse stock split. There are 14,374,478 Public Warrants and 8,499,999 Sponsor Warrants outstanding. After the reverse stock split, the number of warrants outstanding remains the same. However, each outstanding warrant is now exercisable for one-tenth of a share of Class A common stock, and the exercise price per share was adjusted to $115.00 as a result of the split.

X
- Definition Stockholders’ Equity (Details) [Line Items] + References No definition available. + Details
Name: | celu_StockholdersEquityDetailsLineItems
Namespace Prefix: | celu_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of warrants or rights outstanding. + References No definition available. + Details
Name: | us-gaap_ClassOfWarrantOrRightOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_WarrantsAndRightsOutstandingMaturityDate
Namespace Prefix: | us-gaap_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=celu_DragasacWarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=celu_PublicWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=celu_SponsorWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=celu_MayTwoThousandTwentyTwoPrivateInvestmentInPublicEquityWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=celu_MarchTwoThousandTwentyThreePrivateInvestmentInPublicEquityWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=celu_MarchTwoThousandTwentyThreePrivateInvestmentInPublicEquityWarrantsModifiedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=celu_MarchTwoThousandTwentyThreeLoanWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=celu_AprilTwoThousandTwentyThreeRegisteredDirectWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=celu_AprilTwoThousandTwentyThreeRegisteredDirectWarrantsModifiedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=celu_MayTwoThousandTwentyThreePrivateInvestmentInPublicEquityWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=celu_JuneTwoThousandTwentyThreeWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=celu_JuneTwoThousandTwentyThreeLoanWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=celu_JulyTwoThousandTwentyThreeRegisteredDirectWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |